These constraints on the BTNX NTS are extremely appropriate, as we found e.g. etodesnitazene to have a similar in vitro potency and efficacy as fentanyl [7, thirteen] and as it might likely give PWUD a false feeling of protection. Also, the detectability of nitazene analogues in drug samples might be impacted by solubility challenges, as highlighte